Equity Capital Markets

Company · CIK 1840229

MiNK Therapeutics, Inc.

CIK1840229 (SEC EDGAR)
Industry (SIC)2836 — Biological Products, (No Diagnostic Substances)
Incorporated inDE
Business addressNY
ListedINKT (Nasdaq)
First annual or quarterly report2021-11-29

Offerings

4 registrations
RegistrationLabel and statusFirst filedLast eventFilings
333-291388
ShelfEffective
 2025-11-072025-12-112
333-268143
ShelfEffective
 2022-11-032025-08-224
333-281522
ShelfEffective
 2024-08-132024-08-162
333-259503
IPOFinal prospectus
 2021-09-142021-10-154

Filings

13
FiledFilingRegistrationAccession
2025-12-11EFFECTDeclared effective 333-2913889999999995-25-003665
2025-11-07S-3Shelf registered 333-2913880001193125-25-272532
2025-08-22424B5Shelf takedown 333-2681430001193125-25-186417
2025-07-15424B5Shelf takedown 333-2681430001193125-25-159014
2024-08-16EFFECTDeclared effective 333-2815229999999995-24-002571
2024-08-13S-3Shelf registered 333-2815220001193125-24-199818
2022-11-08EFFECTDeclared effective 333-2681439999999995-22-003237
2022-11-03S-3Shelf registered 333-2681430001193125-22-277009
2021-10-15424B4Final prospectus 333-2595030001193125-21-300184
2021-10-14EFFECTDeclared effective 333-2595039999999995-21-003881
2021-10-12S-1/AAmendment 333-2595030001193125-21-296215
2021-09-14S-1Registration filed 333-2595030001193125-21-271914
2021-01-22DRSDraft made public 377-040740000950123-21-000524

All filings of this company · CSV